Search

everythinglearnresearchcommunity

for

Search:↓

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

Homeopathic remedies can help manage PCOS symptoms in girls aged 17-21.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Women with acne after adolescence are more likely to have PCOS and should be checked for it.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Injecting cosyntropin into grizzly bears increases blood cortisol but doesn't change hair cortisol levels.